Align Technology Inc (ALGN) Q3 2026 Earnings Call Highlights: Record Doctor Submitters
Align Technology (ALGN) reported Q3 2026 earnings with record 91,000 doctor submitters (+3% YoY) and Clear Aligner shipments up 6.6% to 691,000. Non-GAAP operating margin was 24.4%, exceeding outlook. Revenue growth slowed to 1.9% YoY, with Systems & Services revenue down 7.6%. ASP declined 2.3% YoY. Q4 guidance was reduced due to consumer challenges and lower ASP assumptions. The company highlighted innovation in sports mouthguards and margin improvement plans for 2027.
How this was made
The 30-second read
Why it matters
Management highlighted strong international growth but warned of lower ASP and reduced Q4 guidance.
Market read
Earnings mix of growth and guidance cut creates a mixed outlook for the dental aligner sector.
What to watch
International 3D‑printing technology and entry into the $6‑8B sports mouthguard market could open new revenue streams.
Background
Align Technology released its Q3 2026 earnings call transcript.
Ticker impact
Q3 results showed record doctor submitters but lowered Q4 revenue guidance and declining aligner ASP, pressuring the stock.
likely downside as market prices in lower Q4 revenue and margin outlook
Guidance reduction and ASP decline signal revenue pressure despite strong international volume.
Market effects
Dental aligner market faces pricing pressure, could affect equipment and consumable peers.
APAC growth offsets some US weakness, highlighting regional divergence.
Signals broader consumer slowdown in orthodontics and potential shift to lower‑priced solutions.
Counterpoint
Despite guidance cut, record doctor submissions and new 3D‑printing mouthguard line may sustain longer‑term growth.
Key entities
- CEOJoseph Hogan
Provided commentary on execution and consumer environment.
- CFOJohn Morici
Discussed margin improvement plans and guidance assumptions.
